Hot Features
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the develo... 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.07 | 5.07246376812 | 1.38 | 1.52 | 1.36 | 37433 | 1.47022354 | CS |
| 4 | -0.24 | -14.201183432 | 1.69 | 1.7 | 1.3582 | 60316 | 1.48009145 | CS |
| 12 | -1.66 | -53.3762057878 | 3.11 | 3.55 | 1.29 | 266122 | 2.18594896 | CS |
| 26 | 0.42 | 40.7766990291 | 1.03 | 8.62 | 0.34 | 2254959 | 4.28571801 | CS |
| 52 | -1.57 | -51.9867549669 | 3.02 | 8.62 | 0.34 | 1296452 | 3.9393826 | CS |
| 156 | -2.3 | -61.3333333333 | 3.75 | 8.65 | 0.0861 | 1430648 | 1.98059547 | CS |
| 260 | -2.3 | -61.3333333333 | 3.75 | 8.65 | 0.0861 | 1430648 | 1.98059547 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.